FdaApplication
NDA 021777
Identifiers
- fda_app_no: NDA021777
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS INTERNATIONAL GMBH |
| application_type | NDA |
| approval_date | 2007-02-01 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AMRIX | CYCLOBENZAPRINE HYDROCHLORIDE | 15MG | CAPSULE, EXTENDED RELEASE;ORAL |
| AMRIX | CYCLOBENZAPRINE HYDROCHLORIDE | 30MG | CAPSULE, EXTENDED RELEASE;ORAL |
2 products